logo
Retired NYPD cop drains savings to help son fight rare brain cancer

Retired NYPD cop drains savings to help son fight rare brain cancer

Yahoo10-03-2025

(NewsNation) — Retired NYPD Lt. Eric Dym is no stranger to battles, but now he and his family face their toughest fight yet — his 7-year-old son's rare cancer.
His son, Derek, was diagnosed a year ago with diffuse midline glioma (DMG), a rare brain cancer that affects approximately 300 children annually.
Dym said his family has paid $5,000 for a 30-day supply of prescription medication and faced potential costs of $40,000 for another 30-day prescription.
Despite having what he thought was comprehensive insurance coverage, Dym told NewsNation on Sunday he's facing crushing medical bills.
Pitt student vanishes on spring break trip to Dominican Republic
'Being employed by the NYPD in retirement, I have full medical, full dental, I have prescription, and you figure it would be the best,' Dym said. 'But unfortunately, you find out where the rubber meets the road.'
The family has exhausted their 401(k)s and maxed out credit cards to cover expenses that insurance wouldn't.
'The deductibles, the co-pays, just the expenses that are associated with this type of disease are exhausting,' Dym said.
The diagnosis forced the family to abandon plans for a backpacking tour through Asia. They now live in an RV near Los Angeles Children's Hospital.
Do vaccines cause autism? CDC to investigate
Derek is currently receiving in-home hospice care. His father describes the cancer as 'not curable at this time.'
Despite the financial strain, Dym refuses to give up.
A GoFundMe campaign was created to help with the medical expenses, with a goal of $600,000.
Dym, who retired from the NYPD as a lieutenant in September 2022, said there's 'no measure' to what a parent will do for their child.
'If that means sleeping on the street, we'll do it,' he said. 'Whatever it takes.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

1.7 million air conditioners recalled over reports of mold growth
1.7 million air conditioners recalled over reports of mold growth

The Hill

time2 days ago

  • The Hill

1.7 million air conditioners recalled over reports of mold growth

(NewsNation) — About 1.7 million window air conditioning units have been recalled in the U.S. after 17 customers reported getting sick from fungal growth in the appliance. The Midea U and U+ window air conditioners may fail to drain quickly, causing mold growth that 'poses risks of respiratory issues or other infections to some consumers,' according to the U.S. Consumer Product Safety Commission. Nearly 46,000 units were also sold in Canada. There have been 152 reports of mold in the white AC units, including 17 reports of people saying exposure to the fungi made them cough, sneeze or have other allergic reactions. Units were sold under the brand names: The Midea air conditioners fit in windows and resonated with consumers because of their unique design, which allows consumers to close their windows 'through' the unit. The units were sold from March 2020 through May 2025 for $280 to $500 in-store and online at Costco, Menards, Best Buy, Home Depot and more. Customers who purchased the units can get a free repair or potentially a prorated refund by contacting Midea. Consumers who choose to use their air conditioners while awaiting a repair can go to to find out how to inspect their unit before continuing to use it. For more information, consumers can visit and click on 'Recall Information' or call (888) 345-0256 from 8 a.m. to 5 p.m. ET Mondays-Fridays. The Associated Press contributed to this report.

‘She always said, 'I'm going to be famous, dad'': Teen dies after viral TikTok ‘dusting' challenge
‘She always said, 'I'm going to be famous, dad'': Teen dies after viral TikTok ‘dusting' challenge

Yahoo

time2 days ago

  • Yahoo

‘She always said, 'I'm going to be famous, dad'': Teen dies after viral TikTok ‘dusting' challenge

The parents of a 19-year-old who dreamed of fame and died after trying the TikTok 'dusting' trend are warning others about its deadly risks. Renna O'Rourke and her boyfriend DoorDashed aerosol keyboard cleaner to her parents' Tempe, Arizona, home without her mother's knowledge, Dana O'Rourke told 12 News. The dusting trend, also known as chroming or huffing, involves inhaling common household cleaners to get high for views online. The sensation causes brief euphoria but can cause instant, fatal damage, often due to heart failure, according to the Cleveland Clinic. After inhaling the keyboard cleaner, Renna went into cardiac arrest, spent a week unconscious in the intensive care unit, and then was declared brain-dead. Renna's parents described their late daughter as 'vivacious and caring and loyal.' Her father, Aaron O'Rourke, told 12 News that Renna loved to sing and lit up every room with her smile and laughter. 'She always said, 'I'm going to be famous, dad. Just you watch. I'm going to be famous,' and unfortunately, this is not under the most optimal of circumstances,' Aaron O'Rourke, told the outlet.. Despite the less-than-ideal circumstances, the O'Rourke family is now working to honor Renna by spreading the word about the dangers of huffing for teens and parents. 'There's no ID required. It's odorless. It's everything kids look for. They can afford it, they can get it, and it doesn't show in mom and dad's drug test,' Dana O'Rourke told AZ Family about access to the trendy chemicals. She added, 'Don't take your kid's word for it. Dig deep. Search their rooms. Don't trust — and that sounds horrible, but it could save their life.' A GoFundMe started to help the O'Rourke family with hospital bills, burial and therapy costs, and to spread awareness about huffing has surpassed its $5,000 goal and sits at over $9,000 at the time of publication.

Family blames cost of Walgreens asthma meds for son's death
Family blames cost of Walgreens asthma meds for son's death

Yahoo

time2 days ago

  • Yahoo

Family blames cost of Walgreens asthma meds for son's death

(NewsNation) — A Wisconsin family is suing Walgreens after they say the rising costs of asthma medication led to the death of their 22-year-old son last year. Cole Schmidtknecht suffered from asthma his entire life, and one day tried to get a refill on his inhaler — only to find out his medication, which typically cost less than $70, had skyrocketed to $500. He had a severe asthma attack five days after his pharmacy visit, stopped breathing, and collapsed, according to his father. Schmidtknecht never regained consciousness and died. Doctors attributed his death to asthma. Woman dies from brain-eating amoeba after using tap water to clear sinuses: CDC 'Cole became very accustomed to asthma,' said Bil Schmidtknecht. 'His struggles were very traditional, as any asthmatic has. He was fortunate to have health insurance through us as he grew up. And we were very versed on asthma, as I have it and Shanon has it too. From a young age, we taught him how to manage it.' Shanon Schmidtknecht, Cole's mother, revealed he had never had issues getting his medication before the incident, nor had she and her husband. 'It wasn't until I went to pick up Bill's same medication on the same insurance plan that we had realized what happened with the price increase,' she added. Schmidtknecht's death caught the attention of Rep. Jake Auchincloss, D-Mass., who shared his story on the House floor in December. 'Cole had his whole life ahead of him,' Auchincloss said. 'Because Cole was forced to choose between paying his rent or shelling out hundreds of dollars to cover his medication out of pocket for a drug that did not need to be that expensive, his family is without their loved one. There's no justification for a family facing Thanksgiving without their child. Cole's death was preventable.' Scientists hooking flies on cocaine to study addiction: Reports Now, the Schmidtknecht family has chosen legal action against Walgreens and OptumRX. They allege OptumRX violated Wisconsin law by raising the cost of the medication without a valid medical reason and failing to provide 30 days' advance notice of drug price increases. 'There's blame to go around to OptumRX and Walgreens Pharmacy,' said Michael Trunk, the family's attorney. 'We have a young man who was on Advair Diskus for a decade, actively and effectively controlling his asthma.' Walgreens, in a statement, said, 'Walgreens extends its deepest condolences over the tragic loss of Cole. While we are unable to discuss specific patient interactions due to privacy restrictions, in general, in cases where a medication is not covered by insurance, pharmacy staff may work with the plan patient, and/or prescriber in an effort to process and dispense the prescription if able.' According to the Allergy and Asthma Network, the cost to treat asthma per person is $3,300. Currently, 28 million people are suffering from asthma in the U.S, which amounts to $82 billion annually for health care costs. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store